Inventor · disambiguated record
Andrew G. Cole
Also filed as: COLE ANDREW · COLE ANDREW G · COLE ANDREW GRAHAM
16 granted patents·24 pending applications·94 citations·filing 2006–2022
91Inventor score
Files withARBUTUS BIOPHARMA CORP13LIGAND PHARM INC5PHARMACOPEIA DRUG DISCOVERY4PROXIMAGEN LLC3GILEAD PALO ALTO INC2
Top patents by PatentIndex Score
40 records- 0195US7723340B2Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2006·Granted May 25, 2010·46 cites·51 claims
- 0288US10995091B2CXCR4 receptor antagonistsPROXIMAGEN LLC·Filed 2018·Granted May 4, 2021·3 cites·14 claims
- 0387US10030034B2Heterocycle amines and uses thereofLIGAND PHARM INC·Filed 2016·Granted Jul 24, 2018·5 cites·12 claims
- 0487US7662819B2Pteridinone derivatives for use as stearoyl CoA desaturase inhibitorsGILEAD PALO ALTO INC·Filed 2007·Granted Feb 16, 2010·15 cites·17 claims
- 0585US10155761B2CXCR4 receptor antagonistsPROXIMAGEN LLC·Filed 2017·Granted Dec 18, 2018·4 cites·16 claims
- 0685US9266874B2Heterocycle amines and uses thereofLIGAND PHARM INC·Filed 2013·Granted Feb 23, 2016·2 cites·9 claims
- 0784US10604533B2Heterocycle amines and uses thereofLIGAND PHARM INC·Filed 2018·Granted Mar 31, 2020·1 cites·15 claims
- 0883US11186593B2Heterocycle amines and uses thereofLIGAND PHARM INC·Filed 2020·Granted Nov 30, 2021·1 cites·19 claims
- 0983US9353086B2CXCR4 receptor antagonistsSAVORY EDWARD DANIEL·Filed 2011·Granted May 31, 2016·6 cites·17 claims
- 1082US7951803B28-heteroarylpurine MNK2 inhibitors for treating metabolic disordersPHARMACOPEIA LLC·Filed 2007·Granted May 31, 2011·10 cites·20 claims
- 1176US11773110B2Heterocycle amines and uses thereofLIGAND PHARM INC·Filed 2021·Granted Oct 3, 2023·0 cites·11 claims
- 1275US11566002B2Substituted tetrahydrocyclopenta[C]pyrroles, substituted dihydropyrrolizines, analogues thereof, and methods using sameARBUTUS BIOPHARMA CORP·Filed 2019·Granted Jan 31, 2023·1 cites·50 claims
- 1372US2022348577A1CXCR4 Receptor AntagonistsPROXIMAGEN LLC·Filed 2021·Application pending·0 cites
- 1460US2009312320A1Methods of treatment comprising the administration of haloaryl substituted aminopurines or compositions thereofSIGNAL PHARM LLC·Filed 2009·Application pending·0 cites
- 1556US2024246964A1Substituted 1-aryl-1’-heteroaryl compounds, substituted 1,1’-biheteroaryl compounds, and methods using sameARBUTUS BIOPHARMA CORP·Filed 2022·Application pending·0 cites
- 1656US2024228504A1Substituted tricyclic amides, analogues thereof, and methods using sameARBUTUS BIOPHARMA CORP·Filed 2021·Application pending·0 cites
- 1755US2023312481A1Substituted (phthalazin-1-ylmethyl)ureas, substituted n-(phthalazin-1-ylmethyl)amides, and analogues thereofARBUTUS BIOPHARMA CORP·Filed 2021·Application pending·0 cites
- 1855US2023295115A1Substituted isoquinolinylmethyl amides, analogues thereof, and methods using sameARBUTUS BIOPHARMA CORP·Filed 2021·Application pending·0 cites
- 1953US2016046606A1CXCR4 Receptor AntagonistsPROXIMAGEN LTD·Filed 2015·Application pending·0 cites
- 2053US2023143612A1Substituted 1,1'-biphenyl compounds and methods using sameARBUTUS BIOPHARMA CORP·Filed 2021·Application pending·0 cites
- 2153US2023108906A1Substituted bicyclic and tricyclic ureas and amides, analogues thereof, and methods using sameARBUTUS BIOPHARMA CORP·Filed 2020·Application pending·0 cites
- 2251US2023083973A1Substituted cyclopropyl-2,2'-bipyrimidinyl compounds, analogues thereof, and methods using sameARBUTUS BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 2351US2023019280A1Substituted isoindolonyl 2,2'-bipyrimidinyl compounds, analogues thereof, and methods using sameARBUTUS BIOPHARMA CORP·Filed 2020·Application pending·0 cites
- 2449US2023045421A1Substituted arylmethylureas and heteroarylmethylureas, analogues thereof, and methods using sameARBUTUS BIOPHARMA CORP·Filed 2019·Application pending·0 cites
- 2548US2022125771A1Substituted polycyclic carboxylic acids, analogues thereof, and methods using sameARBUTUS BIOPHARMA CORP·Filed 2020·Application pending·0 cites
- 2647US11098010B2Substituted dihydroindene-4-carboxamides and analogs thereof, and methods using sameARBUTUS BIOPHARMA CORP·Filed 2018·Granted Aug 24, 2021·0 cites·32 claims
- 2746US2011071130A12-aminobenzimidazoles for treating neurodegenerative diseasesPHARMACOPEIA INC·Filed 2007·Application pending·0 cites
- 2846US2008146536A12-Aminoimidazopyridines for treating neurodegenerative diseasesPHARMACOPEIA INC·Filed 2006·Application pending·0 cites
- 2944US2009005568A1Substituted 2-aminothiazoles for treating neurodegenerative diseasesPHARMACOPEIA DRUG DISCOVERY·Filed 2006·Application pending·0 cites
- 3044US2021251991A1Substituted 2,2'-bipyrimidinyl compounds, analogues thereof, and methods using sameARBUTUS BIOPHARMA CORP·Filed 2019·Application pending·0 cites
- 3143US11001564B2Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using sameARBUTUS BIOPHARMA CORP·Filed 2017·Granted May 11, 2021·0 cites·20 claims
- 3243US2009023723A1Purinone derivatives for treating neurodegenerative diseasesPHARMACOPEIA DRUG DISCOVERY·Filed 2006·Application pending·0 cites
- 3343US2009105283A13-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORSKOLTUN DMITRY·Filed 2008·Application pending·0 cites
- 3442US2011230480A18-heteroarylpurine mnk2 inhibitors for treating metabolic disordersCOLE ANDREW G·Filed 2011·Application pending·0 cites
- 3542US2007225304A1Aminopurine derivatives for treating neurodegenerative diseasesPHARMACOPEIA DRUG DISCOVERY·Filed 2006·Application pending·0 cites
- 3641US11236055B2Non-systemic TGR5 agonistsVENENUM BIODESIGN LLC·Filed 2017·Granted Feb 1, 2022·0 cites·23 claims
- 3741US2008312215A1Substituted [1,4]-diazepanes as CXCR3 antagonists and their use in the treatment of inflammatory disordersPHARMACOPEIA DRUG DISCOVERY·Filed 2006·Application pending·0 cites
- 3839US10669242B2Clostridium difficile toxin inhibitorsVENENUM BIODESIGN LLC·Filed 2017·Granted Jun 2, 2020·0 cites·27 claims
- 3939US2008255161A13-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORSKOLTUN DMITRY·Filed 2008·Application pending·0 cites
- 4039US2010113463A1PTERIDINONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORSGILEAD PALO ALTO INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andrew G. Cole files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →